‘Fish Pedicure’ a Recipe for Bacterial Infection, Researchers Warn
THURSDAY, May 17 (HealthDay News) — “Fish pedicures” in health spas can expose recipients to a host of pathogens and bacterial infections, a team of researchers warns.
Good Health is Your Greatest Wealth……Virgil
THURSDAY, May 17 (HealthDay News) — “Fish pedicures” in health spas can expose recipients to a host of pathogens and bacterial infections, a team of researchers warns.
One of life’s simple pleasures just got a little sweeter. After years of waffling research on coffee and health, even some fear that java might raise the risk of heart disease, a big study finds the opposite: Coffee drinkers are a little more likely to live longer. Regular or decaf doesn’t matter.
(Reuters) – Human Genome Sciences Inc said on Thursday it had adopted a stockholder rights plan as the biotechnology company defends itself against a $2.6 billion hostile takeover bid by drugmaker GlaxoSmithKline Plc. Human Genome said its board determined the $13-a-share bid by the British drugmaker was inadequate and undervalued the company, and it recommended stockholders not tender their shares. …
Editor's Note: Barbara Starr is in Amman, Jordan covering the Eager Lion 2012 exercise. Watch for her stories on CNN next week. By Barbara Starr With a photo of a raging lion over their shoulders, senior U.S. and Jordanian generals opened …
CNN Security Clearance
More than half of U.S. adults aren't getting enough exercise, according to a sweeping new report on the state of America's health from the Centers for Disease Control and Prevention. Older people, ages 75 and older, were the least likely to …
The Full Feed from HuffingtonPost.com
(Reuters) – Adding Johnson & Johnson’s advanced prostate cancer drug, Zytiga, to hormone therapy before surgery has been shown for the first time to eradicate tumors in some men with high-risk forms of the disease. The mid-stage trial found that six months of treatment with the combination therapy completely or nearly eliminated the cancer in a third of patients, all of whom had localized, aggressive cancer. …
(Reuters) – Two drugs being developed by GlaxoSmithKline Plc – each designed to block different pathways used by cancer cells – have been shown in a small clinical trial to curb melanoma with fewer side effects than current therapies. The experimental drugs are dabrafenib, designed to work in patients with a mutation of a gene known as BRAF, and trametinib, which interferes with a protein known as MEK. The drug combination was tested in patients with advanced melanoma and a mutation in the BRAF gene. About half of all melanomas – the deadliest form of skin cancer – have the genetic aberration. …
White births in the United States are no longer in the majority, according to US Census Bureau data made public Thursday.